0.1999
price up icon2.46%   0.0048
 
loading
Vor Biopharma Inc stock is traded at $0.1999, with a volume of 1.90M. It is up +2.46% in the last 24 hours and down -70.60% over the past month. Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
See More
Previous Close:
$0.1951
Open:
$0.199
24h Volume:
1.90M
Relative Volume:
1.05
Market Cap:
$24.98M
Revenue:
-
Net Income/Loss:
$-112.46M
P/E Ratio:
-0.1219
EPS:
-1.64
Net Cash Flow:
$-99.89M
1W Performance:
+13.19%
1M Performance:
-70.60%
6M Performance:
-75.98%
1Y Performance:
-85.08%
1-Day Range:
Value
$0.1917
$0.2044
1-Week Range:
Value
$0.1652
$0.2044
52-Week Range:
Value
$0.1311
$1.80

Vor Biopharma Inc Stock (VOR) Company Profile

Name
Name
Vor Biopharma Inc
Name
Phone
617-655-6580
Name
Address
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
Name
Employee
168
Name
Twitter
Name
Next Earnings Date
2024-11-05
Name
Latest SEC Filings
Name
VOR's Discussions on Twitter

Compare VOR with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
VOR
Vor Biopharma Inc
0.1999 22.07M 0 -112.46M -99.89M -1.64
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-26-22 Initiated Wedbush Outperform
Apr-27-22 Initiated Goldman Neutral
Dec-17-21 Initiated H.C. Wainwright Buy
Dec-03-21 Initiated Robert W. Baird Outperform
Dec-02-21 Initiated Oppenheimer Outperform
Oct-19-21 Initiated JMP Securities Mkt Outperform
Mar-25-21 Initiated B. Riley Securities Buy
Mar-03-21 Initiated Barclays Overweight
Mar-03-21 Initiated Evercore ISI Outperform
Mar-02-21 Initiated Goldman Sell
Mar-02-21 Initiated Stifel Buy
View All

Vor Biopharma Inc Stock (VOR) Latest News

pulisher
May 28, 2025

Vor Biopharma Inc (NASDAQ: VOR) Stock Forecast: Could Pass $6 In A Year - Stocksregister

May 28, 2025
pulisher
May 27, 2025

Vor Biopharma’s SWOT analysis: biotech firm halts programs, explores options - Investing.com

May 27, 2025
pulisher
May 23, 2025

Vor Biopharma Approves Share Increase at Annual Meeting - TipRanks

May 23, 2025
pulisher
May 20, 2025

Vor Biopharma Appoints Robert Ang as CFO - TipRanks

May 20, 2025
pulisher
May 19, 2025

What Did We Note About Insider Trading At Vor Biopharma Inc (NASDAQ: VOR)? - Stocksregister

May 19, 2025
pulisher
May 17, 2025

FMR LLC's Strategic Acquisition of Vor Biopharma Inc Shares - GuruFocus

May 17, 2025
pulisher
May 16, 2025

Vor Biopharma Inc. (NYSE:VOR) Given Consensus Rating of “Hold” by Analysts - Defense World

May 16, 2025
pulisher
May 15, 2025

Vor Biopharma Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 15, 2025
pulisher
May 14, 2025

Vor Biopharma Inc. SEC 10-Q Report - TradingView

May 14, 2025
pulisher
May 12, 2025

Research Analysts’ Recent Ratings Updates for Vor Biopharma (VOR) - Defense World

May 12, 2025
pulisher
May 11, 2025

Vor Biopharma (NYSE:VOR) Cut to “Hold” at Jones Trading - Defense World

May 11, 2025
pulisher
May 11, 2025

JMP Securities Reiterates “Market Perform” Rating for Vor Biopharma (NYSE:VOR) - Defense World

May 11, 2025
pulisher
May 11, 2025

Vor Biopharma’s (VOR) Neutral Rating Reiterated at Wedbush - Defense World

May 11, 2025
pulisher
May 10, 2025

Vor Biopharma (VOR) Downgraded by HC Wainwright & Co. from Buy t - GuruFocus

May 10, 2025
pulisher
May 10, 2025

VorBio (VOR) Downgraded Amid Strategic Review Announcement | VOR Stock News - GuruFocus

May 10, 2025
pulisher
May 09, 2025

Vor Biopharma (VOR) Drops Sharply After Downgrades and Operational Halt - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Stifel cuts Vor Biopharma stock rating amid clinical and financial concerns By Investing.com - Investing.com South Africa

May 09, 2025
pulisher
May 09, 2025

VorBio (VOR) Downgraded as Company Explores Strategic Alternativ - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Stifel cuts Vor Biopharma stock rating amid clinical and financial concerns - Investing.com Canada

May 09, 2025
pulisher
May 09, 2025

Vor Biopharma stock draws downgrades (VOR:NASDAQ) - Seeking Alpha

May 09, 2025
pulisher
May 09, 2025

Layoff Tracker: Shape, Vor Cut Workforces - BioSpace

May 09, 2025
pulisher
May 09, 2025

Vor Biopharma (VOR) Downgraded by JMP Securities | VOR Stock New - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Baird Downgrades Vor Biopharma to Neutral From Outperform - marketscreener.com

May 09, 2025
pulisher
May 09, 2025

This International Paper Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday - Benzinga

May 09, 2025
pulisher
May 09, 2025

Vor Biopharma (VOR) Downgraded by HC Wainwright & Co. from Buy to Neutral | VOR Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Closing Bell Recap: Vor Biopharma Inc (VOR) Ends at 0.16, Reflecting a -70.12 Downturn - DWinneX

May 09, 2025
pulisher
May 09, 2025

VorBio (VOR) Downgraded as Company Shifts Strategy | VOR Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

VorBio (VOR) Downgraded as Company Explores Strategic Alternatives | VOR Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Stifel Downgrades Vor Biopharma, Inc. (VOR) to Hold - StreetInsider

May 09, 2025
pulisher
May 08, 2025

Baird cuts Vor Biopharma stock rating, slashes target to $0.25 By Investing.com - Investing.com Nigeria

May 08, 2025
pulisher
May 08, 2025

Baird cuts Vor Biopharma stock rating, slashes target to $0.25 - Investing.com

May 08, 2025
pulisher
May 08, 2025

Jones Trading cuts Vor Biopharma stock rating to Hold By Investing.com - Investing.com Nigeria

May 08, 2025
pulisher
May 08, 2025

Crude Oil Gains Over 2%; US Foods Posts Downbeat Earnings - Benzinga

May 08, 2025
pulisher
May 08, 2025

Jones Trading cuts Vor Biopharma stock rating to Hold - Investing.com

May 08, 2025
pulisher
May 08, 2025

Vor Biopharma stock plummets on operation wind-down - Investing.com Australia

May 08, 2025
pulisher
May 08, 2025

Vor Biopharma stock plummets on operation wind-down By Investing.com - Investing.com Canada

May 08, 2025
pulisher
May 08, 2025

Vor Biopharma Terminates CFO Han Choi - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

Vor Bio Announces Exploration Of Strategic Alternatives To Maximize Shareholder Value - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

Wedbush Downgrades Vor Biopharma to Neutral From Outperform, Adjusts Price Target to $0.40 From $7 - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

Vor Bio (VOR) Downgraded to Hold as Strategic Alternatives Explored | VOR Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Jones Trading Downgrades Vor Biopharma, Inc. (VOR) to Hold - StreetInsider

May 08, 2025
pulisher
May 08, 2025

Dow Jumps Over 200 Points; US Initial Jobless Claims Fall - Benzinga

May 08, 2025
pulisher
May 08, 2025

Vor Bio (VOR) Explores Strategic Alternatives Amid Operational Wind Down | VOR Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Vor Biopharma (VOR) Announces Exploration of Strategic Alternatives, Winding Down Operations - StreetInsider

May 08, 2025
pulisher
May 07, 2025

Marshall Wace LLP Sells 79,445 Shares of Vor Biopharma Inc. (NYSE:VOR) - Defense World

May 07, 2025
pulisher
May 05, 2025

Vor Biopharma Inc expected to post a loss of 25 cents a shareEarnings Preview - TradingView

May 05, 2025
pulisher
May 01, 2025

XTX Topco Ltd Acquires New Position in Vor Biopharma Inc. (NYSE:VOR) - The AM Reporter

May 01, 2025
pulisher
Apr 28, 2025

Crescent Biopharma Appoints David Lubner to Board of Directors - The Manila Times

Apr 28, 2025
pulisher
Apr 26, 2025

PureTech Founded Entity Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined with a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML) - The Globe and Mail

Apr 26, 2025
pulisher
Apr 26, 2025

Vor Biopharma faces Nasdaq delisting over low stock price - Investing.com

Apr 26, 2025
pulisher
Apr 26, 2025

Vor Biopharma faces Nasdaq delisting over low stock price By Investing.com - Investing.com India

Apr 26, 2025

Vor Biopharma Inc Stock (VOR) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
Cap:     |  Volume (24h):